ID: ALA307991

Max Phase: Preclinical

Molecular Formula: C8H10N4

Molecular Weight: 162.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCc1nc2cc(N)ccc2[nH]1

Standard InChI:  InChI=1S/C8H10N4/c9-4-8-11-6-2-1-5(10)3-7(6)12-8/h1-3H,4,9-10H2,(H,11,12)

Standard InChI Key:  RHRBZOCKNVBXCP-UHFFFAOYSA-N

Associated Targets(non-human)

Matrix metalloproteinase 9 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 162.20Molecular Weight (Monoisotopic): 162.0905AlogP: 0.60#Rotatable Bonds: 1
Polar Surface Area: 80.72Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.45CX Basic pKa: 7.94CX LogP: -0.37CX LogD: -1.01
Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.54Np Likeness Score: -1.30

References

1. Wang X, Choe Y, Craik CS, Ellman JA..  (2002)  Design and synthesis of novel inhibitors of gelatinase B.,  12  (16): [PMID:12127537] [10.1016/s0960-894x(02)00365-7]

Source